World J Gastrointest Surg
January 2024
Background: Oncostatin M (OSM) is a pleiotropic cytokine which is implicated in the pathogenesis of inflammatory bowel disease (IBD).
Aim: To evaluate the prognostic role of OSM in IBD patients.
Methods: Literature search was conducted in electronic databases (Google Scholar, Embase, PubMed, Science Direct, Springer, and Wiley).